Tremfya Shows Over 2x Greater Reduction in MRI-Assessed Inflammation at Week 24
J&J said Tremfya demonstrated over 2x greater reduction in MRI-assessed inflammation versus placebo at week 24.
J&J said Tremfya demonstrated over 2x greater reduction in MRI-assessed inflammation versus placebo at week 24.